Skip to main navigation

>Newsroom
>Careers
- Join Our Team
- Job Opportunities
>Contact
- General Inquiries

Search

Twitter LinkedIn

Our Technology
Our Pipeline
Our Company
Investors

Our Technology
Our Pipeline
- Overview
Our Company
Investors
Newsroom
Careers
- Join Our Team
- Job Opportunities
Contact
- General Inquiries

Investors: Events and Presentations

Events and Presentations

Corporate Presentation

NexImmune Corporate Presentation

Upcoming Events

There are no upcoming events available at this time.

Past Events

November 1 - November 5, 2023

38th Annual Society for Immunotherapy of Cancer Meeting

Enhancement of bispecific T Cell engagers (bispecific TCE) killing potency in AML with NexImmune Artificial Immune Modulation (AIM) Adoptive Cell Therapy (ACT) T cells 735.9 KB

Artificial Immune Modulation (AIM) nanoparticles expand antigen specific CD8 T cells from both naïve and memory T cell populations 4.5 MB

Efficacy of injectable antigen presenting nanoparticles (AIM INJ), in solid tumor models 2.6 MB

June 5, 2023

ASCO Presentation

View Presentation 490.7 KB

February 15, 2023

American Society for Transplantation and Cellular Therapy

View Poster 2.1 MB

September 12, 2022 at 11:00 AM EDT

H.C. Wainwright 24th Annual Global Investment Conference

Listen to webcast

March 17, 2022 at 8:30 AM EDT

Barclays 2022 Global Healthcare Conference

Listen to webcast

January 21, 2022 at 12:00 PM EST

Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) Panel

Click here to register

December 13, 2021

63rd ASH Annual Meeting and Exposition

Preliminary Analysis of a Phase 1/2 Study of NEXI-002 Autologous Multi-Antigen-Specific CD8+ T cells for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) 1.6 MB

September 29, 2021 at 2:00 PM EDT

2021 Cantor Virtual Global Healthcare Conference

Listen to webcast

September 10, 2021 at 1:15 PM EDT

Morgan Stanley 19th Annual Global Healthcare Conference

Listen to webcast

June 22, 2021 at 9:20 AM EDT

Raymond James 2021 Human Health Innovation Conference

Listen to webcast

Pagination

Current page 1
Page 2
Next page
Last page

Overview
Press Releases
Events and Presentations
Financials and Filings
Stock Information
Corporate Governance
Email Alerts
Contact

Our Technology
AIM™ NT Platform
AIM™ ACT Adoptive Cellular Therapy
AIM™ INJ Direct Injection
Abstracts and Publications
Our Pipeline
Overview
Careers
Join Our Team
Job Opportunities

Our Company
Overview
Leadership
Board of Directors
Scientific Advisors
Autoimmune and Infectious Diseases SAB
Newsroom
Latest News
Archives
Media Inquiries
Contact
General Inquiries

Investors
Overview
Press Releases
Events and Presentations
Financials and Filings
Stock Information
Corporate Governance
Email Alerts
Contact

About Us

NexImmune is a rapidly growing leader in the emerging field of antigen-directed immunotherapies. We are developing a novel technology platform with broad application across multiple disease areas.

Our Vision is to conquer cancer and life-threatening immune-mediated conditions by directing natural, disease-specific immune responses.

9119 Gaither Road
Gaithersburg, MD 20877

Twitter LinkedIn

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to NexImmune, its subsidiaries or affiliates. No use of any NexImmune trademark, trade name, or trade dress in this site may be made without the prior written authorization of NexImmune, except to identify the product or services of the company.

© NexImmune, Inc.. All Rights Reserved. 2024

Terms of Use
Privacy
Cookies